All News Archive — Page 137 of 170
-
July 19, 2023
Holowatyj receives National Cancer Institute MERIT Award
Vanderbilt's Andreana Holowatyj, PhD, MSCI, has received the National Cancer Institute’s Method to Extend Research in Time Award to support her ongoing investigation into how early-onset colorectal cancer and its treatments impact reproductive health. -
July 18, 2023
The Alliance for Genomic Discovery announces founding biopharma members: AbbVie, Amgen, AstraZeneca, Bayer and Merck
Illumina Inc., in collaboration with Nashville Biosciences LLC, a leading clinical and genomic data company and wholly owned subsidiary of Vanderbilt University Medical Center, have announced the five founding new members of the Alliance for Genomic Discovery. -
July 18, 2023
Alliance for Genomic Discovery FAQs
Here are frequently asked questions about Vanderbilt University Medical Center's Alliance for Genomic Discovery. -
July 17, 2023
Alzheimer’s genetic risk tracked across sex, race
A Vanderbilt study of genetic risks for cognitive impairment later in life uses data from 32,426 research participants ages 60 and older to elaborate these risks across sex and across the intersection of sex and race. -
July 11, 2023
Aspirnaut scientific symposium set for Friday, July 14
The Vanderbilt University Medical Center community is invited to attend a scientific symposium on Friday, July 14, presented by high school participants in the Aspirnaut K-20 STEM pipeline for diversity and wellness. -
July 10, 2023
Gannon receives career achievement award for islet biology research
Vanderbilt's Maureen Gannon, PhD, received the Paul Lacy Medal Award, the highest honor given by the Midwest Islet Club in recognition of meritorious career achievement in the field of islet biology. -
July 7, 2023
Novel treatments for fake patients
A customizable framework uses simulated patients to distinguish effects of a new treatment from “learning effects” for clinicians; it should help identify training opportunities and hasten treatment improvements.